Advances in strategies of improving solubility and permeability of taxanes
10.16438/j.0513-4870.2017-0863
- VernacularTitle:改善紫杉烷类药物低水溶性和低渗透性的策略探讨
- Author:
Tian-yun HAO
1
;
Yuan-feng WEI
1
;
Shuai QIAN
1
;
Jian-jun ZHANG
2
;
Yuan GAO
1
Author Information
1. School of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China
2. School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
- Publication Type:REVIEWS
- Keywords:
taxanes;
oral preparation;
low solubility;
low permeability
- From:
Acta Pharmaceutica Sinica
2018;53(1):54-61
- CountryChina
- Language:Chinese
-
Abstract:
As a new generation of anti-tumor drugs, taxanes has a good clinical efficacy in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, head and neck cancer. However, low bioavailability of oral administration from low water solubility and low permeability significantly limited the development of their oral applications. Currently, the marketed preparations were non-oral drug preparations, and the injection contained a large number of surfactants (cremophor EL or Tween 80) and organic solvents (ethanol), which could result in fluid retention, hypersensitivity and other side effects, as well as poor compliance. Oral preparation will be an ideal form for development of taxanes medicines. According to the research by our and other groups in recent years, we investigate the technical strategies enhancing the water solubility and absorptive permeability to improve their oral bioavailability. Among them, we emphasize the application prospects of crystallography technology, and provide a theoretical basis to guide future research in the development of oral preparations for taxanes.
